Free Trial

Northrop Grumman (NOC) Stock Forecast & Price Target

$536.74
-0.84 (-0.16%)
(As of 10/4/2024 ET)

Northrop Grumman - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
9
Buy
5

Based on 15 Wall Street analysts who have issued ratings for Northrop Grumman in the last 12 months, the stock has a consensus rating of "Hold." Out of the 15 analysts, 1 has given a sell rating, 9 have given a hold rating, and 5 have given a buy rating for NOC.

Consensus Price Target

$523.20
-2.52% Downside
According to the 15 analysts' twelve-month price targets for Northrop Grumman, the average price target is $523.20. The highest price target for NOC is $605.00, while the lowest price target for NOC is $435.00. The average price target represents a forecasted downside of -2.52% from the current price of $536.74.
Get the Latest News and Ratings for NOC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Northrop Grumman and its competitors.

Sign Up

NOC Analyst Ratings Over Time

TypeCurrent Forecast
10/7/23 to 10/6/24
1 Month Ago
9/7/23 to 9/6/24
3 Months Ago
7/9/23 to 7/8/24
1 Year Ago
10/7/22 to 10/7/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
7 Buy rating(s)
Hold
9 Hold rating(s)
9 Hold rating(s)
8 Hold rating(s)
7 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$523.20$523.20$510.36$503.00
Forecasted Upside-2.52% Downside1.51% Upside18.68% Upside18.85% Upside
Consensus Rating
Hold
Hold
Hold
Hold

NOC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NOC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Northrop Grumman Stock vs. The Competition

TypeNorthrop GrummanAerospace CompaniesS&P 500
Consensus Rating Score
2.27
2.64
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside-2.52% Downside39.42% Upside7.04% Upside
News Sentiment Rating
Positive News

See Recent NOC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/27/2024Alembic Global Advisors
3 of 5 stars
 DowngradeOverweight ➝ Neutral$560.00+9.36%
8/9/2024Morgan Stanley
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$579.00 ➝ $592.00+20.48%
7/30/2024Barclays
3 of 5 stars
 Boost TargetEqual Weight ➝ Equal Weight$470.00 ➝ $500.00+4.70%
7/29/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$440.00 ➝ $515.00+6.89%
7/29/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$474.00 ➝ $575.00+19.72%
7/26/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$593.00 ➝ $605.00+25.30%
7/26/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$475.00 ➝ $500.00+4.97%
7/26/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$467.00 ➝ $509.00+8.18%
6/26/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Madrid
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$565.00+31.86%
6/21/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Harned
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$477.00+9.79%
6/18/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$530.00 ➝ $500.00+16.19%
4/26/2024Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetPositive ➝ Positive$540.00 ➝ $560.00+16.32%
4/26/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$475.00 ➝ $505.00+3.44%
12/14/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradePeer Perform ➝ Underperform$450.00-7.21%
10/31/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$430.00 ➝ $435.00-7.73%
7/28/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$655.00 ➝ $615.00+36.76%
7/28/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$502.00 ➝ $485.00+8.91%
4/28/202322nd Century Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
4/27/2023Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Safran
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
2/6/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$500.00 ➝ $490.00+11.20%
1/27/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$500.00 ➝ $478.00+7.79%
1/13/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell$440.00 ➝ $375.00-23.15%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 11:20 PM ET.


Should I Buy Northrop Grumman Stock? NOC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, October 1, 2024. Please send any questions or comments about these Northrop Grumman pros and cons to contact@marketbeat.com.

Northrop Grumman
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Northrop Grumman Co.:

  • Northrop Grumman Co. stock price has been steadily increasing, reaching $518.54 on the latest trading day, indicating positive momentum.
  • Recent insider activity shows confidence in the company's future prospects, with company insiders owning 0.22% of the stock.
  • Analyst ratings have been generally positive, with several analysts giving the stock a "buy" rating and price targets above the current value.
  • Northrop Grumman Co. has a strong market cap of $76.74 billion, indicating stability and potential for growth.
  • The company's financial ratios, such as the debt-to-equity ratio of 1.03 and current ratio of 1.11, suggest a healthy financial position.

Northrop Grumman
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Northrop Grumman Co. for these reasons:

  • Recent analyst downgrades from "outperform" to "market perform" may indicate potential challenges or headwinds for the company.
  • Despite positive insider activity, the total value of shares sold by insiders over the last ninety days amounts to $1,393,028, which could raise concerns among investors.
  • While the stock has shown positive performance, the P/E ratio of 36.15 and P/E/G ratio of 2.36 may suggest the stock is currently overvalued.
  • Some analysts have issued a "hold" rating on the stock, indicating a more cautious approach to investing in Northrop Grumman Co.
  • The beta of 0.34 for Northrop Grumman Co. suggests lower volatility compared to the market, which may limit potential returns for investors seeking higher risk-reward opportunities.

NOC Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Northrop Grumman is $523.20, with a high forecast of $605.00 and a low forecast of $435.00.

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Northrop Grumman in the last year. There is currently 1 sell rating, 9 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NOC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NOC, but not buy additional shares or sell existing shares.

According to analysts, Northrop Grumman's stock has a predicted downside of -2.52% based on their 12-month stock forecasts.

Over the previous 90 days, Northrop Grumman's stock had 1 upgrade and 1 downgrade by analysts.

Northrop Grumman has been rated by research analysts at Alembic Global Advisors, Barclays, Deutsche Bank Aktiengesellschaft, Morgan Stanley, Royal Bank of Canada, TD Cowen, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Northrop Grumman less than other "aerospace" companies. The consensus rating for Northrop Grumman is Hold while the average consensus rating for "aerospace" companies is Moderate Buy. Learn more on how NOC compares to other companies.


This page (NYSE:NOC) was last updated on 10/6/2024 by MarketBeat.com Staff
From Our Partners